News for Rhinomed Limited (RHNMF)

Wilmington, Delaware, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled,

Research finds finds most Australians are still medicating with illicit cannabis, although numbers accessing legal prescription have risen.

The first of new products is set to be delivered by the end of FY23.

The competition to become the world’s supplier of medicinal cannabis is hotting up. Australian weed companies are getting into the action.

Missouri and Maryland have just voted to legalise weed and Arkansas, North Dakota and South Dakota could be next.

Read the ultimate guide on ASX cannabis stocks, companies and pricing. Gain advice to uncover market conditions and investing opportunities.

Researchers say data shows transition from illicit to legal use of cannabis, with medicinal users up 34.5% since 2018.

Like a teenager on a first date, Aussie markets opened enthusiastically, before wilting in a disappointing fashion, only to rise again.

The ASX lost ground on Thursday, weak leads out of Wall Street, more threats of Western-led sanctions v. Russia